Global Vitiligo Epidemiology Forecast to 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The “Vitiligo - Epidemiology Forecast - 2025” report has been added to ResearchAndMarkets.com’s offering.Vitiligo - Market Insights, Epidemiology and Market Forecast - 2025 provides an overview of the disease and in depth research related to Vitiligo for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Vitiligo. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Vitiligo for 7 major markets. The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the report highlights the frontrunners, the drivers and barriers for the Vitiligo market, as well as treatment algorithm, current treatments & advancements are included. The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Vitiligo, providing an in-depth analysis of emerging therapies which will create an impact through their launch.
Key Coverage:Understanding historical and forecasted epidemiological data for Vitiligo covering 7MM from 2015-2025.Segment level epidemiology and market split for Vitiligo.The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Vitiligo.The report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Vitiligo market trends.Thorough market distribution based on market share for Vitiligo.
Key Topics Covered:
1. Report Introduction
2. Vitiligo Epidemiology Overview at a Glance
4. Epidemiology and Patient Population
5. Prevalent Population of Vitiligo in 7MM
6. Epidemiology of Vitiligo
7. United States
13. United Kingdom
15. AppendixFor more information about this report visit https://www.researchandmarkets.com/research/zmkmwt/global_vitiligo?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005316/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Dermatological Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/11/2018 04:36 AM/DISC: 09/11/2018 04:36 AM